ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,195Medicare Part D Prescriptions Filled, Including Refills

Rank: 26 out of 337

$607K Total Retail Price of All Prescriptions

Rank: 44 out of 337

482 Patients Receiving at Least One Drug in Part D
84%Patients 65 Years and Older
23% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Rhode Island
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 482 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

9% of this provider’s 482 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

1% of this provider’s 12,122 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$43 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Rhode Island
SIMVASTATIN 1,132 952 1 1
LISINOPRIL 709 643 2 2
OMEPRAZOLE 562 484 3 4
METFORMIN HCL 428 380 4 12
ATORVASTATIN CALCIUM 421 379 5 7
FUROSEMIDE 418 386 6 8
QUINAPRIL HCL 369 338 7 50
AMLODIPINE BESYLATE 349 324 8 3
METOPROLOL TARTRATE 348 338 9 6
LEVOTHYROXINE SODIUM 319 297 10 5
HYDROCHLOROTHIAZIDE 311 287 11 9
ZOLPIDEM TARTRATE 280 225 12 23
ALENDRONATE SODIUM 265 263 13 19
CITALOPRAM HBR 248 195 14 17
TRAZODONE HCL 226 179 15 16
SERTRALINE HCL 204 185 16 18
ATENOLOL 171 126 17 10
LOVASTATIN 164 151 18 24
HYDROCODONE-ACETAMINOPHEN 156 104 S3 19 13
PRAVASTATIN SODIUM 149 112 20 14
FLUTICASONE PROPIONATE 149 112 20 34
LIPITOR 141 123 22 33
TRAMADOL HCL 137 97 23 32
METOPROLOL SUCCINATE 135 126 24 21
TAMSULOSIN HCL 129 128 25 25
BISOPROLOL-HYDROCHLOROTHIAZIDE 121 117 26 95
DIOVAN 121 116 26 26
TRIAMTERENE-HCTZ 115 97 28 39
GLIPIZIDE ER 114 114 29 69
PROAIR HFA 113 91 30 38
ALLOPURINOL 111 105 31 28
NAPROXEN 108 85 32 98
WARFARIN SODIUM 103 96 33 11
MELOXICAM 100 86 34 54
GABAPENTIN 95 73 35 20
LISINOPRIL-HYDROCHLOROTHIAZIDE 90 80 36 31
CARVEDILOL 89 77 37 73
DILTIAZEM ER 85 85 38 169
SPIRIVA 82 70 39 43
LEVOXYL 82 73 39 90
GLIPIZIDE 80 80 41 45
CRESTOR 76 66 42 29
DILTIAZEM 24HR ER 75 67 43 76
LOSARTAN POTASSIUM 74 70 44 15
NEXIUM 73 62 45 56
PROPRANOLOL HCL 73 61 45 121
GEMFIBROZIL 73 72 45 114
IBUPROFEN 70 51 48 64
DIOVAN HCT 69 55 49 88
PLAVIX 66 66 50 74
NADOLOL 64 64 51 156
ADVAIR DISKUS 64 47 51 44
MIRTAZAPINE 62 58 53 27
BACLOFEN 61 35 54 133
EVISTA 58 58 55 102
PAROXETINE HCL 58 50 55 46
RANITIDINE HCL 58 34 55 30
PANTOPRAZOLE SODIUM 58 58 55 36
GLYBURIDE 57 47 R 59 53
FLUOXETINE HCL 55 42 60 57
DIGOXIN 55 45 60 58
DIVALPROEX SODIUM 54 16 62 101
CLOPIDOGREL 51 51 63 42
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 5, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.